针对神经性下泌尿道功能障碍的β3-腺素受体激活剂:第一线治疗的证据和临床理由
Sharon E Fishberg1,2, Rano Matta1,2
1Department of Surgery, Sunnybrook Health Sciences Centre, Division of Urology, University of Toronto, Toronto, Ontario, Canada.
Neurourology and urodynamics
|November 6, 2025
概括
贝塔3-上腺受体激动剂是有效和安全的管理神经性下尿路功能障碍 (NLUTD). 这些激动剂优化膀储存,并保护上部通道,副作用比其他治疗方法少.
科学领域:
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 药理学 药理学是指药理学的学科.
- 神经科学是一个神经科学.
背景情况:
- 神经性下尿路功能障碍 (NLUTD) 显著影响患有脊髓损伤 (SCI),多发性硬化症 (MS) 和脊柱裂变等疾病的患者.
- 目前的管理策略旨在优化膀储存,防止上道损伤,改善生活质量.
研究的目的:
- 审查当前关于β3-腺受体激动剂在治疗NLUTD中的有效性和安全性的证据.
- 评估它们在膀储存优化和上道保护中的作用.
- 将它们的安全性与现有疗法进行比较.
主要方法:
- 随机对照试验,元分析和观察性研究的系统审查.
- 专注于患者群体,包括SCI,MS和脊柱裂.
- 评估膀储存参数,患者报告的结果以及心血管/认知安全.
主要成果:
- 贝塔3-上腺体受体激应剂 (例如,Mirabegron,Vibegron) 改善囊泡计容量并降低排毒器压力.
- 分析证实了对生活质量和膀功能的好处.
- 心血管安全性令人放心,在试验和队列研究中没有发现过度风险.
- 与抗糖药物相比,β3-激动剂显示出更有利的认知安全概况.
结论:
- 贝塔3-上腺受体激动剂是一种安全,有效和耐受良好的NLUTD的第一线治疗方法.
- 它们提供了改善的膀安全性和失禁性,并减少了全身副作用.
- 基于β3激动剂的治疗策略为NLUTD管理提供了一个理性的,以患者为中心的方法.
相关概念视频
01:18Adrenergic Agonists: Therapeutic Classification
1.4K
Adrenergic agonists can be classified based on their therapeutic uses and mechanisms of action. They serve various purposes in clinical applications.
Vasopressor or pressor agents: They increase blood pressure and function as cardiac stimulants. Examples include endogenous catecholamines (norepinephrine and dopamine) and synthetic agents (phenylephrine).
Bronchodilators: β2-agonists can relax bronchial muscles and widen airways. They are commonly used for treating obstructive pulmonary...
Vasopressor or pressor agents: They increase blood pressure and function as cardiac stimulants. Examples include endogenous catecholamines (norepinephrine and dopamine) and synthetic agents (phenylephrine).
Bronchodilators: β2-agonists can relax bronchial muscles and widen airways. They are commonly used for treating obstructive pulmonary...
1.4K
01:22Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers
1.4K
α-Adrenergic antagonists, known as α-blockers, exert their effects by inhibiting α-adrenoceptors, leading to specific physiological actions. α1-blockers and α2-blockers have distinct pharmacological actions and therapeutic applications.
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally,...
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally,...
1.4K
01:30Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
239
A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
239
01:30Adrenergic Agonists: Therapeutic Uses
1.6K
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
1.6K
01:31Adrenergic Antagonists: ɑ and β-Receptor Blockers
1.1K
Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is...
1.1K
01:30Adrenergic Agonists: Direct-Acting Agents
2.6K
Drugs that mimic the action of endogenous catecholamines like noradrenaline and adrenaline are called adrenergic agonists or sympathomimetics. Based on their mechanism of action, sympathomimetics can be classified as direct-, indirect-, or mixed-acting sympathomimetics. Direct-acting adrenergic agonists activate adrenoceptors without affecting presynaptic neurons, making them independent of neuronal catecholamine-depleting agents like reserpine and guanethidine.
These agents can be classified...
These agents can be classified...
2.6K